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ABSTRACT 
Purpose: The alternative nicotine delivery systems (ANDS) market is complex, with a range of multi-
national and multi-sector stakeholders competing for market share but also clashing ideologically as 
the evidence about the impact and side-effects of ANDS emerges. This empirical study examines the 
beliefs, goals and emotions at the heart of the practices performed by actors within the organisations 
behind the controversial commercial explosion of ANDS.  
Design/methodology/approach: The study was designed to explore business strategies from the 
viewpoints of ANDS business stakeholders. A purposive, snowball sampling strategy was used to 
recruit ANDS stakeholders and gatekeepers among UK tobacco multinational and independent 
companies 
(n=28). Data were then analysed using a market-as-practices theoretical framework which specifically 
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frames market activities as practices, governed by teleoaffective structures, which seek to establish 
market procedures and rules, and which contribute to the taste regimes of a consumer practice.  
Findings: Analysis has indicated that the ANDS market is highly contested and volatile, interwoven with 
competition, emotion and conflicting beliefs. In this context, there are commercial practices routinely 
undertaken in an attempt to align stakeholders’ beliefs, which is seen as a core part of the corporate 
activities required within the marketplace. A key driver of these alignment activities is the profit end-
goal, but this is in tension with beliefs, such as about doing ‘right’ and the objectivity of ‘science’. Beliefs 
across this emergent market vary and are strongly held, and they lead to emotional positions, tying back 
to why aligning stakeholders is difficult. Analysis illuminates how the projects, end goals, emotions and 
beliefs which comprise the teleoaffective structures of various corporate practices in the ANDS market 
might inform the rules and norms of the market, shaping a taste regime experienced by consumers. 
Limitations: The data and analysis cannot account for the beliefs and emotions of public health bodies, 
researchers, the media, policymakers and other stakeholders, but seek to illuminate how teleoaffectivity 
is a key part of market practices. Furthermore, the taste regimes of ANDS consumers cannot be 
observed in the data due to the focus on ANDS corporate actors. Finally, it is possible that conscious or 
unconscious biases in the interviewing style may have driven interviewees’ responses and influenced 
data interpretation. 
Implications: Tobacco control is one of the greatest success stories of public health; smoking prevalence 
has been driven down with a combination of popular empowerment and corporate containment. All this 
depended on a coherent and accepted evidence base. As this evidence base has fractured during the 
evolution of the ANDS market, so the stories have proliferated and progress has become less certain. 
The high emotion in the ANDS market indicates a tougher task for behaviour change activity targeting 
corporate actors. 
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Contribution: This paper speaks to the multiple calls in the behaviour change literature to tackle the 
intractable problems of the day through upstream measures including the restriction of corporate 
activity. The value is in the unique dataset and in the ambition of the project to unravel behind-the-
scenes activities in the ANDS market. A practice-theoretical framework, although conceptually complex, 
is deployed to capture the complex intertwining of multiple practices and thus attempt to grasp the full 
significance of teleoaffectivity in the marketplace.  
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INTRODUCTION  
 
This paper speaks to the multiple calls in the behaviour change literature to tackle the intractable 
problems of the day through upstream measures including the restriction of corporate activity (Hoek & 
Jones, 2011; Lefebvre, 2011). This is logical given the force of corporate marketing activities in shaping 
consumer tastes and choices on a cultural scale (Grier & Kumanyika, 2008; Shove & Pantzar, 2005; 
Shove & Southerton, 2000). In the UK, regulation of tobacco industry activity tipped the balance in 
favour of a cultural shift away from smoking. However, the case of alternative nicotine delivery systems 
(ANDS) is more complex.  
For proponents of tobacco harm reduction (THR), and the UK in particular where tobacco harm 
reduction has been largely embraced (though this is approach is contested internationally), ANDS have 
been held up as a ‘potential public health silver bullet’ (Freeman, 2017, p. 19). Ostensibly, the 
motivations behind the companies marketing ANDS as reduced risk products are difficult to understand, 
given that some are also the multinational tobacco companies. But the situation is more complicated 
due to other companies marketing ANDS – independents with no tobacco industry (TI) ties – and these, 
either small local or larger national, independent stakeholders have very different interests and 
motivations (Bauld, Angus, de Andrade et al., 2016; Hasselbalch, 2016). Adding further complexity, is the 
way these products ‘arrived’ onto the market: ANDS were a consumer-driven revolution, so from the 
start the product was more aligned with the values of consumers or other stakeholders, and not with 
the tobacco industry who joined the market much later (Bauld et al., 2016; MacKenzie, Eckhardt & 
Prastyani, 2017). This suggests empowered consumers, rather than the passive victims of corporate 
marketing dependent on top-down protections depicted above. To complicate matters further still, in 
some countries there are now bans on the marketing of e-cigarettes (e.g. the UK, Finland, and other 
Member States via the EU Tobacco Products Directive) (Russell, Wainwright, & Tilson, 2016).  
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In view of this complexity, our understanding of the ANDS market needs to expand to make sense of the 
myriad strategic activities of the multiple stakeholders. For just the corporate stakeholders, for example, 
those activities include engaging with public health, research and evidence, policymakers and the media. 
Engagement and relationship building work is vital for corporate actors given that the evidence for long-
term impacts on health is preliminary and often contradictory, although there is largely agreement that 
ANDS are less harmful than tobacco. Key opinion leaders, scientists, health bodies, regulators, 
journalists and advocates argue over which approach in THR is the ‘right’ approach (Sim & Mackie, 2014; 
McNeill, Brose, Calder et al., 2015). While there are many overlapping viewpoints, divided opinions are 
often put forward (in the media and in academic and practitioner journals, for example) as a crude pro- 
versus anti-tobacco harm reduction division (see for example Gornall, 2015). Corporate actors must 
navigate a pathway through the public discourse, and insodoing seek to steer and influence powerful 
others who can shape the market and regulatory landscape for their future business. 
Doing business in the ANDS market is complex, and especially so given the overlaps and blurred lines 
between the new ANDS market and the old, much maligned Tobacco Industry (TI). Much of the tension 
and speculation around the TI’s business interests in ANDS is informed by its deceptive past (Chapman, 
2014; Gilmore & Hartwell, 2014; Grana, Benowitz, & Glantz, 2014; The Lancet, 2013). Some academics 
state that for industry this is about business not public health noting how transnational tobacco 
companies use the term tobacco harm reduction ‘as opportunistic tactical adaptation to policy change 
rather than a genuine commitment to harm reduction’ (Peeters & Gilmore, 2015, p.186). Evidence also 
suggests that British American Tobacco’s (BAT) early interest in smokeless tobacco in Europe was 
steered by business interests and the possibility of generating an alternative form of tobacco use, 
particularly among young people (Peeters & Gilmore, 2013). However, others describe ANDS ‘as a 
possible game-changing product that can end the use of combustible cigarettes once and for all’ (Glynn 
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2014, p.165). For example, Philip Morris (the world’s largest tobacco company) has pledged US$1 billion 
to a new Foundation for a Smoke-Free World headed by a former World Health Organization (WHO) 
executive and THR advocate (Meyer, 2017).  
Despite the contested background to ANDS, the market is growing. Nielsen data for the UK gave the e-
cigarettes category a retail sales value of £174.6m up to autumn 2016, an increase of 20% from the 
previous year, on sales volumes up 31% (Selwood, 2017). The global e-cigarette market was valued at 
US$11.92 billion with a growth rate of 31% in 2016 and the market is forecast to reach US$26 billion by 
2020 (Technavio, 2016). North America has been the market leader since 2013. In 2015, its share was 
40.92% followed by the UK and other countries in Western Europe where the market recorded revenues 
valued at US$2.71 billion (Technavio, 2016). Although news media coverage has grown over the past 
few years (e.g. Rooke & Amos, 2014), the battleground between the various stakeholders is largely 
invisible to the consumers but the UK’s cultural taste for ANDS is growing, as demonstrated by the 
permeation on social media (Zhan, Liu, Li et al., 2017; Glowacki, Lazard & Wilcox, 2017; Lazard, Saffer, 
Wilcox et al., 2016) and the social and collective spaces for vaping communities (e.g. Burnley Football 
Club, 2013; Fisher, 2016; Williams, 2015). 
In this context, analysis of the ANDS market requires careful consideration. Of particular interest is how 
the consumer taste for ‘vaping’ has developed and the role of corporate and other stakeholders in 
shaping this taste. A traditional conceptualisation of a market is based on the principles of exchange, 
and views consumers and marketers as rational actors each seeking the best exchange to meet their 
own ends. Rarely do marketing textbooks stray from this simple economic premise to talk about how 
the emotions and beliefs of actors within corporate organisations and among other stakeholders, which 
may not be explicit, act on consumer tastes and behaviour. By contrast, these texts do say a great deal 
about consumer emotions. This paper explores primary research with key actors in the TI and 
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independent organisations behind ANDS which suggests that their emotions, beliefs and end goals are 
paramount within commercial marketing activities, guiding – and in turn framed by – their overall 
business purpose. Importantly, this paper considers the implications of the emotions and beliefs of 
corporate and independent actors, and has chosen to do this via the theoretical mechanisms of 
‘teleoaffective structures’ and ‘taste regimes’; both emanating from a practice theoretical perspective. 
The social context has been identified in the tobacco control literature as significant for our 
understanding of how the practice of smoking takes hold and survives (Blue, Shove, Carmona, et al., 
2016; Poland, Frohlich, Haines, et al., 2006), and various models of behaviour which emphasise social 
influences on behaviour have been used to analyse smoking behaviour (e.g. Corbett, 2001; Unger, 
Shakib, Gallaher, et al., 2006). However, much of this literature still places the consumer at the centre of 
analysis, rather than considers the consumer to be one part of a complex marketplace system of 
practices. Poland et al. (2006, p.61) go so far as to offer that ‘the marketing practices of the tobacco 
industry are implicated’ in our understanding of some of the ways consumers engage with the practices 
of tobacco use, but their reference to marketplace practices ends there. This paper places the 
marketplace practices making up the ANDS market at the centre of analysis. Specifically, we attempt to 
unravel the role of emotions, beliefs and end goals in the ANDS market, but also attempt to achieve a 
position that can take into consideration the very contested, political and emotive context of ANDS. 
This research draws centrally on practice theory to help understand the role of corporate and 
independent stakeholder beliefs and emotions in the market system of practices. Practices are patterns 
of behaviour “which can be ﬁlled out by a multitude of single and often unique actions reproducing the 
practice… The single individual – as a bodily and mental agent – then acts as the ‘carrier’… of a practice – 
and, in fact, of many different practices which need not be coordinated with one another” (Reckwitz, 
2002, pp.249-50). As such, a practice approach stands “in opposition to individualist ontologies where 
social phenomena are viewed as products arising out of the actions and mental states of individuals, and 
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societism understood as the study of social facts, structures and systems that resist reduction to 
individual actors” (Araujo, Kjellberg & Spencer, 2008, p.6). Practice-theoretical enquiry involves a focus 
on the connections between material things, embodied skills, mental representations and their 
configuration (Shove & Pantzar, 2005), and less so about individuals’ attitudes or actions in isolation. 
Importantly, this is not about entering into a ‘blame game’ – the “process of interaction among the 
players in these different worlds, as they combine or conflict and seek to pass the blame onto those in 
other worlds” (Hood, 2011, p. 22). Rather, this is an attempt to conceptualise the market. 
The role of belief and emotion are important parts of what makes up a practice; seen to be ‘of the 
practice’ (Warde, 2005) rather than the individual. Indeed, although a range of different models exist 
(Reckwitz, 2002; Shove, Pantzar & Watson, 2012; Warde, 2005), practices can be understood as doings 
and sayings that are linked in three ways: “(1) through understandings, for example, of what to say and 
do; (2) through explicit rules, principles, precepts and instructions; and (3) through… ‘teleoaffective’ 
structures embracing ends, projects, tasks, purposes, beliefs, emotions and moods” (Schatzki, 1996, p.89, 
emphasis added). In the light of this dissection, this research draws on practice theory to consider the 
teleoaffective structures in the constellation or nexus of practices which make up the ANDS market. 
These teleoaffective structures form part of powerful public discourses which are the basis of taste 
regimes, experienced as taste by consumers.  
Following Callon (1998), who rejected the notion that markets are constructions populated by self-
interested agents, we take a practice-theoretical understanding that markets can be conceptualised as a 
network of interrelated and inseparable practices; those of the producers, intermediaries and 
consumers but also policymakers, advocates, academics and media. Each practice impacts the other and 
no activity is outside the system. This system of practices has been called a constellation of practices. 
Schatzki explains: 
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“Practices – organised manifolds of doings and sayings – connect to material arrangements – … 
to form practice-arrangement bundles. Such bundles, in turn, connect to other bundles to form 
wider constellations of practices and arrangements. Social life transpires within these bundles 
and constellations…” (Schatzki, 2017, p.133). 
Elsewhere, Schatzki (2005) writes that organizations are bundles of practices comprising a variety of 
types of practice and that each bundle comprises a set of activities, routines and material arrangements 
that identify them as autonomous practices as well as allowing them to coordinate other bundles inside 
and outside the purview of the organization (Araujo et al., 2008).  
 
Understood in this way, the teleoaffective structures embedded in commercial marketing practices are 
connected to those in consumer practices through relationships between elements across the 
constellation of practices which make up the market system. Practices within the constellation inform 
each other. That is to say that, drawing on Giddens’ theory of structuration (1984), what is at the heart 
of marketing can neither be considered the ‘demands’ or ‘needs’ of the individual consumer, nor any 
form of dominant social-structural totality in the form of ‘the market’ or ‘commercial marketing activity’. 
Rather, ‘marketing’ is made up of a constellation of practices which are recursive. Consumer tastes or 
needs, then, are not simply shaped or manipulated by the ‘market’ but are the result of the interaction 
between consumer practices and market practices.  
Schatzki, Knorr Cetina and von Savigny (2001) define practices as embodied, materially enabled sets of 
human activities organized around shared practical understandings. Whilst interested ultimately in the 
‘shared practical understandings’ of consumers towards ANDS, our research does not focus on 
consumer experience or needs directly. Rather, this study examines the beliefs, goals and emotions at 
the heart of the practices performed by actors within the organisations behind the controversial 
commercial explosion of ANDS.  
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MARKETS AS PRACTICE 
Practice theory has been applied to an eclectic range of marketing and consumption topics such as 
understanding green consumers (Connolly & Prothero, 2003), analysing the practice of DIY (Watson & 
Shove, 2008) and understanding the evolution of wearable tracking technology (Pantzar & Ruckenstein, 
2015). However, the majority of this literature considers individual practices, rather than considering 
markets as practices and understanding the relationship between elements and performances across 
the constellation. However, there are pockets of work which fall within Callon’s thinking, that markets 
are “constructed through a range of practices involving different forms of expertise and material 
devices” (1998, p.61) (e.g. Cochoy, 1998; Järventie-Thesleff, Moisander, & Laine, 2011; Kjellberg & 
Helgesson, 2007; Skålén & Hackley, 2011). Ingram, Shove and Watson (2007, p.3), for example, explore a 
cyclical model of designing and consuming, indicating that “consumer practices stimulate design; and 
that new products stimulate new practices”. They ask whether the ambition of making things could be 
elaborated to move beyond a ‘fit for purpose’ model to include an understanding that things make the 
purposes for which they fit.  
Of particular note is a 2008 special edition in Marketing Theory dedicated to work on market practices 
research. In their introduction, Araujo et al. (2008) define market practices as “the bundles of practices 
including material arrangements that contribute to perform markets” (p.8). Within this definition, they 
make two key points. Firstly they emphasise a preference for studying markets as “ever-changing 
performances, rather than as stabilized entities, shaped by multiple and distributed calculative 
agencies” (p.8). This focus on performance is significant, given that our access point to corporate 
practices in this study is the performance ‘talk’ of the actors who are shaping the corporate practices 
involved in presenting ANDS to the market. Secondly, Araujo and colleagues emphasise how false it is to 
differentiate between market-making practices, including academic commentary, and marketing 
practices, including promotion, advertising and so on. Rather, they see market practices as all “efforts to 
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shape markets as well as efforts to operate in markets qua structures (e.g. to promote, advertise, sell) 
and the intended and unintended interactions between these practices” (p.8). This is significant given 
the focus of this paper on the practices which are undertaken by corporate and independent actors to 
shape the discourses – reconstituted by the media, research and other stakeholders – which are a key 
part of the market system. 
 
The work in the Marketing Theory special edition concentrates attention on occasions when different 
practices can be seen to link together. An example is through Cochoy’s (2008) study of the shopping 
trolley, which both shapes consumer supermarket shopping activity and is shaped by numbers of 
supermarket, regulatory and historical contexts. The body of market practice work also considers the 
role of agency within the practice conceptualisation; the agency of commercial organisations 
(Andersson, Aspenberg & Kjellberg, 2008). Particularly useful is the work of Simakova and Neyland 
(2008), which explores the role of storytelling in the new product development context of a technology 
company. Their study is interested in investigating closely the “instability, messiness and management” 
(p.95) of the relationships between different actors (people and things) in a market system. They do this 
by exploring the storytelling of the marketing team, which is performed to a range of audiences who 
might come together, or unravel, or ignore the story. They emphasise that “launching a product does 
not involve simply sending a product out into the world, but requires the active and ongoing 
management of sets of relations between people and things through which the product will be taken 
up” (p.98). In other words, the company at the heart of Simakova and Neyland’s (2008) study created a 
“tellable story for their own organizational actions. The tellable story involved work to produce a 
coherent account of what it was [the company] had been doing and what they were going to be doing. 
Producing a tellable story involved making sense of the possibility of a product, the possibility of a 
market for that product and doing a range of practical tasks to prepare for those possibilities” (p.100). In 
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the same way as Simakova and Neyland focus on the role of the ‘tellable story’ in the constitution of 
marketing practices, this research focuses on the tellable stories of actors in the ANDS market. 
TASTE REGIMES 
Furthermore, we draw on two theoretical ideas in the framing of our analysis. Firstly, we lean on the 
concept of taste regimes, which Arsel and Bean (2013, p.902) describe as a discursively constructed 
normative system that “regulates acts of consumption by providing the teleoaffective structure of a 
practice that orders objects, meanings, and doings”. Taste regimes shape consumers’ abilities to 
“evaluate, choose, arrange, and use objects in space, and the speciﬁc ways objects are used in everyday 
life” (Arsel & Bean, 2013, p.902) and are therefore important starting points for thinking about the role 
of corporate activity in how they are shaped. In other words, taste regimes are the manifestation of 
discourses which shape the meanings of a complex system of practices. The context for Arsel and Bean 
is home décor, but the same concept can easily be applied to consumption of – and ‘taste’ for – ANDs as 
a public health game changer. The purpose of ‘taste regime’ is to explain how a complex array of 
different interconnected practices is governed by “socio-historically contextualized discursive systems” 
(Arsel & Bean, 2013, p.902). Although there is considerable work on marketplace discourse, this current 
work is predominantly conceptualised in terms of identity construction rather than at the level of 
markets as practice (Ahuvia, 2005; Dong & Tian, 2009; Luedicke, Thompson, & Giesler, 2010).  
Given that the focus of this paper is the commercial activities which are central to the creation of taste 
regimes within a model of markets as practice, we also draw on Kjellberg and Helgesson (2007) to help 
conceptualise these corporate activities as different practices. These authors specify that markets are 
constituted through three connected types of practice. Firstly, there are exchange practices involved in 
the consummation of individual transactions; secondly, there are normalizing practices, which are 
concerned with the formulation and reformulation of rules and norms in the market; and thirdly, there 
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are representational practices, which depict the structure and workings of specific product markets. This 
is a useful model, and helps further pinpoint the focus of this study, which is on the performances of 
corporate and independent actors in the ANDS market whose actions, emotion and beliefs formulate 
the rules and norms of market behaviour via the taste regimes they help create. It is useful to think 
about the constitution of these three types of practice, any of which will contain their own 
teleoaffective structures; “embracing ends, projects, tasks, purposes, beliefs, emotions and moods” 
(Schatzki, 1996, p.89).  
To conclude the theoretical framing of this empirical paper, this research seeks to examine corporate 
and independent sector actors’ talk, and particularly their tellable stories, in the creation of the taste 
regime amongst a network of market stakeholders which is ultimately shaping the widespread 
acceptance of ANDS consumption. In line with a market as practice approach, we conceptualise the 
creation of this taste regime in terms of corporate practices which are concerned with the formulation 
and reformulation of rules and norms in the market. The practices involved in this task contain end goals 
and purposes but also emotions and beliefs, in the form of teleoaffective structures. The illumination of 
these teleoaffective structures, through the tellable stories visible in the data, allows for a view of 
corporate activity which is often missing from accounts of new product development and new market 
penetration and can help us see how the discourses underpinning a particular product, in this case the 
highly contentious ANDS, are created and shaped through commercial practices and in turn relate to the 
beliefs and behaviour of consumers.  
METHODOLOGY  
The paper’s conception arose from a study which systematically examined the business strategies being 
deployed in the e-cigarette/ANDS market (and beyond) by both tobacco multinationals and independent 
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companies, using primary and secondary data. The study sought to compare and contrast their 
respective:  
(i) business approaches 
(ii) targeting strategies 
(iii) positions on harm reduction and health claims 
(iv) marketing plans (including product development, pricing, distribution, packaging and 
promotion). 
Only the interview data are explored in this paper. (Results from the larger study which combined 
analyses of primary and secondary ANDS stakeholder data are submitted elsewhere). 
 
The lead author, a female academic researcher (PhD) with a previous career in investigative journalism, 
arranged and conducted all interviews. She had no established relationships with any of the participants, 
although it was likely some knew of her research and that she had been publicly critical of the marketing 
practices of e-cigarette companies and of tobacco multinationals in the past (de Andrade, Hastings & 
Angus, 2013; Hastings, de Andrade, & Moodie, 2012), and/or had attended the same public health 
meetings. 
Participants were initially selected using a purposive sampling strategy to interview appropriate ANDS 
stakeholders and gatekeepers among UK tobacco multinational and independent companies. Snowball 
sampling was used, via referrals or introductions, to interview additional influential and prominent 
participants until sampling saturation was reached. It was likely saturation was realised because the 
international market has been controlled by as few as five multinational companies for the last decade 
(Campaign for Tobacco-Free Kids, 2016). Approaches were made by email, telephone or in person at 
ANDS events. Participants received a project information sheet and informed consent form, and had 
opportunities to ask questions about the project.  
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Table 1 summarises the data collection settings, interview duration and characteristics of the sample 
(n=28), who were interviewed once only. All interviews were audio-recoded; short field-notes were 
taken during some interviews; and recordings were professionally transcribed. (Copies of their individual 
transcripts were requested by and provided to two participants).  
 
[Insert Table 1 about here] 
 
The study was designed to explore business strategies from the viewpoints of ANDS business 
stakeholders, not to obtain a pro- or anti-THR perspective. ANDS stakeholders have diverse views on the 
topic so interviews were open-ended and shaped by the participant’s response to items (i) to (iv) above. 
The interviewer commenced with an ideological ‘blank sheet’ and the flexible interviewing style 
facilitated open and expressive responses. 
Open coding of the transcripts in an NVivo 11 database was used by two researchers to identify first-
level concepts (see Table 2). Coding was checked by a third researcher. Using techniques of grounded 
theory, discussions of emergent themes and data interpretations were discussed during the inductive 
thematic analysis to inform further interviews, thus ANDS stakeholders could respond to emergent 
findings in an iterative way during interviews (Lingard, Albert & Levinson, 2008). For the purposes of this 
paper, subsequent thematic coding focused on beliefs, goals and emotions expressed by ANDS 
stakeholders (see Table 2). Tobacco company interviewees included individuals who have worked 
for/are working for/with the tobacco industry. 
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TABLE 1 Interview profiles (28 interviewees in total across 25 interviews, conducted between April 2015 
and November 2016) 
Interview 
number 
Tobacco (n=13) or Independent 
(n=15) company 
Approximate length of 
interview (h:m) 
Face-to-face or by 
telephone 
1 Independent 1:50 Telephone  
2 Tobacco 1:00 Telephone 
3 Independent 1:00 Face-to-face 
4 Tobacco [x2]* 1:15 Face-to-face 
5 Independent 1:40 Face-to-face 
6 Tobacco 1:40 Telephone  
7 Tobacco 1:15 Telephone 
8 Tobacco 1:00 Telephone  
9 Tobacco 1:15 Telephone 
10 Tobacco 1:20 Telephone 
11 Tobacco  1:10 Telephone 
12 Independent 1:15 Telephone 
13 Independent 1:10 Telephone 
14 Independent 1:00 Telephone  
15 Tobacco [x2]* 1:50 Face-to-face  
16 Independent 1:40 Face-to-face 
17 Independent 1:30 Telephone 
18 Tobacco [x2]* 1:00 Telephone 
19 Independent 1:10 Telephone  
20 Independent 1:00 Telephone  
21 Independent 0:40 Telephone 
22 Independent 0:50 Telephone  
23 Independent 0:45 Telephone 
24 Independent 0:50 Telephone  
25 Independent 0:50 Face-to-face  
*Interview conducted with 2 interviewees simultaneously. 
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TABLE 2 Coding themes used to analyse the transcripts. 
Open Coding 
Tobacco Industry 
1. Threats to opportunities  
2. Sustainability  
3. Long-term use  
4. TI is not a homogenous entity  
5. Different strategies and goals, motivations  
6. React and adapt 
7. Emerging vs ‘dying’ markets  
8. Transparency 
9. Shareholder value 
10. New tobacco execs, new category, new 
approach 
11. Market share  
12. Full portfolio  
13. Safety, high quality standards  
14. Clear communication of risk 
15. Regulation [to protect the companies vs 
innovation ]  
16. Science 
17. Protect the cigarette  
18. Complete transformation  
19. Competitive advantage  
20. Scale and distribution 
21. Keep the consumer, meet the consumer’s 
needs  
22. Legal 
23. Consolidation [vs innovation]  
24. The Apple/iPhone model: closed vs open 
systems – brand creation [linked to heat not 
burn] 
25. Grow and compete / expand the market 
 
Independent Companies 
1. End of combustibles  
2. Opportunity for profit  
3. Open system / individualised product / 
understanding the consumer  
4. Survival  
5. Retail model 
6. Innovation  
7. Lobbying  
8. Build a brand/ credibility  
 
Other 
1. Battlefield OR battles and discomfort [and 
confusion/and ideology] – between public 
health groups, between TI companies, 
within TI companies / industry is not an 
homogenous mass 
2. Confusion [public health] 
3. Terminology 
4. Ideology 
5. Vested interests  
Thematic Coding  
1. Ideology  
2. Battles  
3. Confusion  
4. Trust  
5. Interests  
6. Values  
7. Science 
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[Insert Table 2 about here] 
Data were then analysed using the theoretical framework detailed above. Findings in the next section 
are the project’s data used to illuminate the teleoaffective structures in the ANDS stakeholders’ 
commercial practices. 
A limitation of our study is that interviews were only with tobacco and independent company ANDS 
representatives. As such, our analysis does not account for the beliefs and emotions of public health 
bodies, researchers, the media, policymakers and other stakeholders. It is also important to 
acknowledge the interviewer’s and authors’ own beliefs, goals and emotions. While every attempt was 
made to abandon pre-existing ideologies, conscious or unconscious biases in the interviewing style may 
have driven interviewees’ responses and influenced data interpretation. The paper adheres to the 
COREQ checklist (Tong, Sainsbury & Craig, 2007), developed to promote explicit and comprehensive 
reporting of qualitative studies. Ethical approval was granted by School of Health in Social Science 
Research Ethics Committee at the University of Edinburgh. 
FINDINGS 
Firstly, analysis illuminates some of the practices involved in the ANDS market system. Description of 
these practices includes ‘pushing’, ‘repositioning’, ‘trying’, ‘supporting’, ‘tying things together’ and 
‘playing stakeholders off against each other’, suggesting a very considered effort to shape stakeholders’ 
beliefs. Our analysis labels these efforts ‘projects’, as per Schatzki’s (1996) list of inclusions within 
teleoaffective structure. Other teleoaffective structures clearly identifiable within the interview 
transcripts include ‘end goals’, ‘emotions and moods’ and ‘beliefs’. The discussion which follows this 
section will explore how the projects, end goals, emotions and beliefs which comprise the teleoaffective 
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structures of various corporate practices inform the rules and norms of the market, shaping a taste 
regime. 
Projects and end goals 
Stakeholder alignment  
The interview data illuminates the efforts taken by ANDS companies to align the beliefs of key 
stakeholders with their own in order to shape the discourse underpinning the new and commercially 
profitable practice of ANDS consumption. A TI (tobacco industry) representative explained that strategy 
in the ANDS space ‘assumes that all sections of society – or someone looking after all the sections of 
society – are pushing things forward’ (int4). The discourse in ‘society’, according to the interviewee, is 
not simply being ‘pushed’ by people working within ANDS marketing and strategy but by other 
stakeholders, especially ‘government’. It was further explained that ‘four parties’ are involved in the 
gathering of this discursive momentum: ‘the people who may choose to use them – the consumers; it 
involves the companies who are making them; it involves the government that sets out whether this is a 
good thing or a bad thing; and then involves scientists actually trying – when it’s a risk strategy – it’s 
scientists trying to figure out’ (int4). The interviewee reflected on the complexity of steering and shaping 
a discourse comprising so many different agencies, people and interests. For example, stakeholder 
misalignment of ‘that four-centred dynamic’ was highlighted as a reason for failed attempts to introduce 
a tobacco harm reduction paradigm shift ‘historically’, adding that ‘those four things had never really 
come together’ (int4). Here, the interviewee’s mention of ‘things’ refers to the four key stakeholder 
groups which they see as underpinning the global discourse around ANDS which is currently ‘very 
different in different parts of the world’ – ‘so UK, it’s almost harmonised; in the US, it’s certainly not; at 
WHO level, it’s not’ (int4). 
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Other interviewees spoke of the complex effort required to ‘tie’ together stakeholder interests. That 
complexity is particularly noteworthy even though, (according to int13, a respondent not related to the 
tobacco industry) all stakeholder agendas with the exception of the TI ‘probably aim at the same focal 
point… to make tobacco irrelevant’ (int13). Furthermore, other independent interviewees reflected on 
the diversity of TI and other stakeholder beliefs including public health advocates, researchers and the 
media. They explained that each stakeholder group can be accused of making ‘unsubstantiated 
accusations that have no basis in truth’ (int19), and this was described as a ‘function of special interests 
and a variety of them, all combined together’ (int19). These ‘different vested interests of different 
groups’ were described as liable to change depending on ‘which company or health organisation’ is 
pushing for a particular interest rather than ‘better align[ing] what we’re doing with the pursuit of the 
health goals that we have in mind’ (int1).  
The picture here is of a discourse around ANDS which emanates from a volatile environment containing 
multiple stakeholders. There is no simple message or agreement amongst stakeholders that ANDS 
relates to reduced or zero tobacco consumption, and the task for the ANDS companies in aligning public 
voices across the stakeholder group is vast and difficult. Although some (non-TI) interviewees suggested 
that history and science would be the real tests about the outcome from ANDS, the data illuminates the 
context of how public discourse comes about and the role of corporate and independent actors in 
actively shaping that discourse. Of particular note is that the discourse is shaped not only by direct 
corporate activities targeting consumers, but also through the alignment of the beliefs of other 
stakeholders in the system, such as health bodies, academics, media and publications. Commercial 
practices involve the push and pull of these stakeholders in order to negotiate the configuration of the 
market. As ensuing data will illustrate, these beliefs and emotions are firmly felt and discussed by the 
interviewees with deep feeling (and often strong language). However, as the next section illustrates, a 
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driving goal for the corporate actors is creating profit, and it is interesting to consider the alignment 
between the articulated beliefs and emotions with the ‘profit’ goal. 
The profit endgame 
Findings suggest that a central end goal associated with any corporate practice within the ANDS market 
is profit maximisation, through achieving competitive advantage and by creating demand, though 
tobacco companies have different competing strategies to achieve this. This pursuit for profit guided by 
the fiduciary imperative – the legal requirement of corporations to always put the interest of their 
shareholders first – is a dominating influence on everything they do. One TI representative explained 
that ANDS offers ‘a paradigm shift for our industry’; ‘an opportunity from a business point of view to 
grow our market share’ and ‘at the same time, it’s good for public health’; ‘both a huge business 
opportunity’ and as ‘the moral, right thing to do’ (int15). This articulation offers a clear alignment of 
corporate and public health goals, but there is also evidence in the data that the alignment of TI’s goal 
for profit-maximisation and public health’s eradication of tobacco has, as int12 put it, ‘been muddied 
and clouded’ by rival tobacco companies having such diverse tobacco harm reduction strategies. An 
independent interviewee added that some cigarette companies are now ‘more against smoking than 
some of the anti-smoking groups in what they’ve said’ (int11).  
Furthermore, there is competition within different parts of the TI, for example, and interviewees 
described this internal competition as having led to ‘all sorts of battles going on internally’ within ‘the 
different components’ of the TI (int1). Even subsidiary companies ‘are deeply competitive organisations’ 
with ‘their own management teams, have their own people with their own interests and are not 
working in concert with each other. They’re constantly looking to take market share off each other’ 
(int3). So, whereas profit and public health goals seem to align, tensions within the TI create a context of 
high stakes and high emotion. For example, one interviewee explained how ‘there is very clear evidence 
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in public fora’ of internal criticism and differences of opinion across the TI (int7). This is understandable 
given the corporate profit-driven agenda, but several respondents spoke about the ‘serious cut-throat 
stuff going on’ between companies (int3) such as publicly presenting data that ‘trashes’ another 
company’s data (int3) and ‘multi-national frickin’ tobacco companies competing on science’ (int2).  
This is where it becomes most evident that ‘all big tobacco is not a homogenous monolith with the exact 
same interests’ (int3). Each company has its own ANDS corporate strategy. Indeed, looking for ‘notion of 
differences… across the industry; how are their interests and intentions different and what are the 
implications of that? … is a really important piece of the puzzle’ (int2). While all TI companies are 
invested in ANDS, they are competing ‘definitely on different levels’ (int21). Whereas on some occasions 
TI companies reportedly join forces with others when beneficial as evident in ‘cross marketing 
arrangements’ (int25) and ‘technology sharing and licensing agreement[s]’ (int3), interviewees also 
noted that ‘the very senior leadership’ are allowing this type of ‘sort of broken up system to take place’ 
within companies – encouraging ‘friction’ between the combustible and THR sides of a company’s 
business. This entails ‘making investments and standing up business lines that are in direct competition 
with each other’ (int9). Paradoxically, ‘the way that [TI] companies have made all their money is what’s 
being threatened by the investments in the new units’ (int9).  
In this conflicted environment, it is possible to see how corporate attempts to align stakeholders into a 
common purpose is unlikely to be a smooth process. Furthermore, as the following two sections 
illuminate, the strength of ‘beliefs’ and ‘emotions’ evident in the interviewees’ accounts suggests a 
further layer of complexity and turmoil infiltrating the ANDS discourse. 
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Beliefs  
Pro- or anti-tobacco harm reduction  
The belief that there are two distinct divisions in the harm reduction debate – stakeholders are either 
pro- or anti-THR – comes out strongly in the data. Public health researchers, health bodies, regulators 
and other stakeholders were placed by interviewees on opposing ends of the THR spectrum: either in 
favour of alternative forms of nicotine to reduce harm caused by smoked tobacco or a cold turkey 
approach to quitting tobacco involving no reduced nicotine consumption. It was noted that some health 
organisations say they have a ‘tobacco-free’ goal – though ‘tobacco is defined as any form of nicotine –
then they’re abstinence only’ which, according to an independent interviewee, means ‘they end up 
getting something that protects the [tobacco] companies’ as it becomes ‘virtually impossible to get a 
reduced risk product to the market’ so tobacco is the only option (int1). This respondent reflected on 
why it is difficult to change these beliefs about tobacco usage for anti-THR stakeholders: ‘[you get] 
deafening silence from people who are still travelling round the world, going to conferences, talking 
about the [tobacco] endgames, presenting their ideas and getting rounds of applause... these people 
benefit from the current paradigm. You know, they’re flying around the world on somebody else’s dime, 
drinking beer with their friends, and being heroes. Why are they gonna change?’ (int1). Findings also 
suggest that a paradigm shift towards a fully embraced tobacco harm reduction approach is complicated 
by strong – often conflicting – beliefs in science. 
Belief in science 
Driving these pro- or anti-THR beliefs, is a fundamental belief in evidence-based practice confounded by 
contradictory results by researchers on opposite sides of the debate. As one independent put it: ‘How 
do you know what’s true, what’s not true? Particularly when it comes down to scientific evidence, 
right?’ (int3). Furthermore, findings reflect the belief that ‘there’s a lot of research being done in this 
field that is driven by political dogma… People are setting up studies with a particular political agenda… 
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all the way from study design through to the way the results are being interpreted and written up, to 
the lack of peer review from major publications, to the press releases that are being issued from so-
called, you know, quality journals, and the way it’s being reported in the media’ (int5). This suggests that 
the public discourse around ANDS is shaped by stakeholders across the market system. In light of this, 
and the earlier commentary about efforts to align stakeholders with the interests of corporate actors, it 
is unsurprising that TI respondents noted a ‘duty’ to contribute to scientific evidence. As int4 explains, 
‘we [TI] have a duty, especially in this one… where there’s so much uncertainty in the health community 
as to whether they’ll be good or bad, that we will publish, absolutely publish on this one’ (int4). Another 
TI interviewee added: ‘no one’s had these types of products before and certainly not with the level of 
scientific substantiation and evidence which we’re compiling’; ‘we are investing a huge amount of time, 
resource, expertise, in the science, to enable those conversations and to objectively look at the best 
route forward’ (int15). Objectivity was questioned by some independent respondents, however, who 
note that ‘everybody doubts Big Tobacco’s science because Big Tobacco can afford to buy results. 
There’s a big difference between buying the results and buying independent research’ (int19). 
The opposing beliefs about ‘science’, argues one respondent, ‘leaves the consumer ineffably baffled’ not 
least because there are health organisations in whom stakeholders have an ‘awful lot of trust’ 
promoting ANDS, ‘and the rest of them saying “No, no, no, no, no. They’re as bad as, or worse than”’ 
(int11). Some independents highlighted ‘distrust of the tobacco industry’ (int16), while others noted 
that tobacco companies ‘know their products inside out and back to front, they’ve got scientists working 
for them who probably know more about some of these issues than anybody else’ so there needs to be 
‘some sort of compromise to be found, where they’re allowed back in, under intensely close scrutiny, 
but their work is not automatically dismissed’ (int5). Clearly, the part of scientific evidence to play in the 
ANDS discourse is contested, and the beliefs of actors in the market carry considerable weight in the 
treatment of this evidence and the way it is voiced. 
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Emotions and moods  
Closely related to ‘beliefs’ is a series of strong emotions that tended to cluster around a few key topics. 
Here, the emotional language, often including vulgarity, is noteworthy, as are the regular references to 
personal perspectives, individual vested interests and seemingly powerful personal motivations for one 
position over another within the contested areas of debate. For example, an interviewee referred to the 
ANDS context as ‘a religious thing. This is a culture war’ (int1) and another described the nature of 
evidence and research in the field as ‘fraught; this one is highly contested’ (int3). This respondent also 
noted that within the ‘public conversation… the loudest voices are the ones that are like, “Rah, rah, fuck 
up. Back off. Get out of our faces, Nanny”’, suggesting undertones of anger and frustration. There was 
yet more generalised emotional language in the interviews in the form of descriptions of personal 
motivations of different stakeholders within the ANDS context. One respondent explained the 
‘disappointment’ that would be felt by ‘a policy person, an anti-smoking person’ who might have ‘spent 
your whole life trying to stamp out smoking’ (int16). However, emotional talk in the interviews tended 
to fit mostly into four areas; trust in science, the contested role of peer reviewed journals, vested 
interests and moralising.  
Trust in science 
The open-ended informal interview style meant emotional articulations often emerged as a stream of 
consciousness and flowed from points raised during the interview. Use of heated language was expected 
given the contested nature of the controversial THR debate, particularly as the interviewer and authors 
of this paper have been publicly critical of private-sector involvement in public health policy and e-
cigarette marketing strategies. Conflicting beliefs on what constitutes ‘true’ science evoked emotional 
responses on how and why researchers, health bodies, the media are misleading the ANDS public 
discourse.  
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In one response, where an independent respondent was reflecting on differences between the tobacco 
and pharmaceutical industries and whether the TI was reinventing itself, the reply started with 
reflection on how some anti-THR public health tobacco control groups are not ‘subject to that same 
vested interest criticism’ as others. It then moved on to criticisms of poorly designed and conducted 
studies – ‘well that’s just scandal! That’s just shit science, right? Really bad. All the way from who 
designed that study, to conducted the study, to who wrote it up (int5)’.  
The role of peer-reviewed journals, media and health bodies  
Int5’s disappointment in the trustworthiness of ‘science’ was linked to the belief that accurate science 
should be upheld, and extended to the journal itself: ‘shame on them for publishing it and press 
releasing it in that way and allowing those articles to be written. I struggle to think of many things that 
are less scientific… not objective, factual, scientific’ (int5). Another respondent referred to the same 
study when asked about what the consumer is meant to do in the face of contradicting science. 
Referring to ‘the crap’ that comes out of some research groups, this independent stakeholder pointed to 
the media’s role in this confusion: ‘there’s nine million smokers who are being told by [tabloids] that it’s 
pointless switching cos it’s gonna kill you just as quick’ (int12). Further to this was the emotive belief 
that it is ‘really, really wrong… this calling people on conflict of interest. That’s just disgraceful’ (int5).  
Personal beliefs, views and vested interests  
Responses demonstrate how personally invested people are in ANDS and how the ‘very rapidly moving 
field’ is ‘further confused because of all the preconceptions, ideological views’ and ‘financial interests’ 
including accepting grants from organisations that have an abstinence only goal (int1). Some 
respondents noted that ‘there are billions of dollars annually going into tobacco control and a lot of 
people are making a very nice living, thank you, out of all of that. And that’s before you look at stop 
smoking services and the likes of [anti-smoking groups]… All of these organisations are all paying their 
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mortgages and they’re all paying their mortgages because of the tobacco industry’ (int12). As a result, 
there were calls for ‘more people being open and honest with their values’ to ‘facilitate an interaction 
going forward between… researchers… and people, now on the tobacco side, and people on the science 
and product side’ (int10). One respondent spoke of the ‘hypocrisy in the form of tobacco control 
movement in this area’, once again commenting ‘a lot of mis-statements about what the science is’ and 
‘a lot of misleading of consumers’ (int8).  
Moralists  
Emotive responses suggest that interviewees have strong opinions about what is ‘right’ and ‘wrong’ or 
‘good’ and ‘bad’ about the way in which personal beliefs in ANDS influence science and the THR agenda. 
Stakeholders with differing views – or ‘moralisers’ (int3) – were described as being separate from the 
topic rather than embroiled in the same issue. An independent respondent explained that anti-THR 
individuals are prejudiced by ‘the tobacco wars and the malfeasance by the tobacco industry’ and this 
‘forms the bedrock for this particular moral panic’ (int3). They added that ‘one’s got to be very careful 
about… being too moralistic about this. You know, the reality is it’s all amoral, as far as these companies 
are concerned’ (int3). It was further suggested by another independent interviewee that those who 
have ‘got an absolutist, ideological position’ are ‘actually standing in the way of making the sorts of 
moves that will really protect the environment’ for the tobacco industry (int1). 
Conclusion to findings 
Analysis has indicated that the ANDS market is highly contested and volatile, interwoven with 
competition, emotion and conflicting beliefs. In this context, there are commercial practices routinely 
undertaken in an attempt to align stakeholders’ beliefs, which are seen as a core part of the corporate 
activities required within the marketplace. A key driver of these alignment activities is the profit end-
goal, but which is also in tension with beliefs about doing ‘right’. Although companies have the same 
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overarching goal of profit maximisation, this is far from a simplifying mechanism given the competing 
beliefs and emotions also at play in the marketplace. Beliefs across this emergent market vary and are 
strongly held, and they lead to emotional positions, tying back to why aligning stakeholders is difficult. 
Harmonisation is further complicated by tightly guarded views by other stakeholders including public 
health bodies, researchers, the media and journals on the science and whether ANDS will contribute to 
the eradication of the tobacco epidemic.  
DISCUSSION  
The discussion explores the implications of analysis which illuminates the various projects, end goals, 
emotions and beliefs within the commercial practices involved in the ANDS marketplace. It is clear that 
to understand the marketplace in such a contested, volatile context requires activities far beyond those 
listed in marketing textbooks, which might include new product development, branding, promotion and 
distribution. Our findings have pointed to the centrality of the multiple and often competing beliefs 
across the multiple stakeholders in the ANDS market, and to the importance of corporate actors 
creating and pursuing ‘tellable stories’ to infiltrate the public discourse around the new product. We 
have illuminated the activities and tensions buried deep in the ANDS marketplace: the stakeholder 
alignment activities, the sometimes internally divisive drive for profit, the competing beliefs around 
tobacco harm reduction and science and the strong emotions which infiltrate marketplace activities and 
discourse. This picture suggests that viewing the market as a constellation of practices is a far more 
fruitful way of understanding marketing in the fullest sense. As a system of practices, reaching far 
beyond any reductive model of consumer-organisation relationship for mutual benefit, it is possible to 
see the ANDS market as an evolving entity, shaped by and comprising the market-making practices of 
the various actors and, rather than in spite of, their tensions, emotions, beliefs and end goals.  
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A significant set of market activities that our findings highlighted was the alignment projects, which are 
part of the ‘normalizing practices’ of commercial actors in the ANDS market. They are concerned with 
the formulation and reformulation of rules and norms in the market, aligning important stakeholders 
with held beliefs and commercial goals. These alignment activities happen against the backdrop of 
competing beliefs, strong emotions and contested evidence. At the most basic level, even the 
effectiveness and outcomes of ANDS is far from settled, and the alignment activities of the market 
players are extremely challenging. Their contested nature is an important part of the set of practices 
making up the ANDS market system. 
Seen as a system of market-making practices, including the various messy stakeholder practices noted 
above, the teleoaffective structures within the practices become important for illuminating the way the 
practices are shaped and what drives them. As a reminder, teleoaffective structures include project 
ends, projects, tasks, purposes, beliefs, emotions and moods (Schatzki, 1996). They are part of the 
practice and are part of what guides and drives it. What is clear in the research findings presented is that 
the teleoaffective underpinnings of the corporate activities in the ANDS marketplace are conflicted and 
intense. The strength of language used by the interviewees offers a glimpse of the ferocity of the mood. 
Where there are beliefs, for example, about anti-tobacco harm reduction or the veracity of some part of 
the canon of scientific evidence, there are strong emotional reactions to stakeholders and whole 
institutions with incompatible views. Such beliefs and emotions, part of the teleoaffective structures 
specific to this particular industry at this particular time, are an important factor within the marketplace.  
The theoretical positioning of this paper argues that the corporate practices in a marketplace system 
contribute to the creation of a taste regime. Although this paper did not examine the tastes of 
consumers, the consumer context is of an explosive market, with sales increasing exponentially year on 
year. The power of consumer tastes for vaping, it would seem, is strong and growing. This is perhaps 
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surprising given the degree of disintegration and embattlement evident in the interviews. However, it 
might suggest that despite the conflicted context, the commercial actors in the marketplace succeed in 
creating a tellable story which is compelling for consumers, and that there has been some success in 
aligning the activities of powerful stakeholders with the interests of commercial organisations. However, 
this potentially simple solution is questionable when considering the role of the media in highlighting to 
consumers the level of conflict between stakeholders, which is highly newsworthy content. Keller and 
Halkier (2014) demonstrate how consumers draw on media discourse as a symbolic resource to position 
themselves in relation to contested consumption activities. Consumers use media to make sense of 
practices and to shape the meanings of the practice. It would seem that consumers are drawing on the 
media discourse around ANDS, along with tellable stories from the corporate and independent actors, 
and negotiating the meanings of ANDS consumption practice which is appealing and is succeeding in 
recruiting more practitioners over time. For the market to thrive, consumers cannot be as ‘ineffably 
baffled’ as one of the respondents suggested. Conflicted practices fail to recruit practitioners, and 
consumers must play their part in overcoming practice conflict. This is a reminder that consumers are an 
important part of the marketplace practices, and that further research into consumer engagements with 
ANDS consumption would be a logical next step in this research endeavour. 
This paper does not try to identify what corporate practices make up the creation of a taste regime, but 
rather illuminate the significance of teleoaffective structures in the corporate activities which make up 
some of the range of market-making practices in the constellation. Beliefs and emotions stand out as 
central, as do end goals. This tells us something about the way that the ANDS market works, and 
particularly about the importance of understanding flows of meaning within a marketplace system, 
rather than restricting analysis to a reductive model of marketing based on consumer-organisation 
exchange. The emotions and beliefs of corporate and independent actors set the scene for a conflicted 
environment in which actors strive for stakeholder alignment in order to achieve a compelling tellable 
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story and generate marketplace norms and a profit-enhancing taste regime. Although out of the direct 
sight of this analysis, within the taste regime, consumers draw on marketplace discourse in their own 
market practices, and co-constitute the taste regime. This view of marketplace practices as a system of 
contingent, contested and teleoaffectively-underpinned practices allows for a fuller understanding of 
how marketplaces work, and treats consumers as part of the system of market practices rather than as 
outside it, or as its objects. 
The ANDS market is likely to be a special case, given the generations of public health campaigning 
around tobacco and the previous mistrust and revelations about the tobacco industry. However, 
stakeholder alignment, and indeed the politicization of marketing, is likely to inform new products of 
multiple types, such as consumer health tracking technology, food and beverage products and 
automobiles. As such, there are clear benefits beyond the ANDS context to viewing markets as 
interlocking practices in which emotions, beliefs and end goals play a central part. 
CONCLUSION  
Continued uncertainty and confusion about the health and wider implications of the growing ANDS 
market fuelled by a highly contested and incomplete evidence base prompted a national consensus 
statement on e-cigarettes led by NHS Health Scotland (2017) with leading health bodies, charities and 
academics ‘to clarify perceptions about any harms and benefits of using e-cigarettes’. It stipulates that 
‘there is now agreement based on the current evidence that vaping e-cigarettes is definitely less harmful 
than smoking tobacco’, though ‘there is still a lot we do not know about e-cigarettes’ and ‘they are not 
risk free’. The statement, coinciding with the launch in England of this year's Stoptober campaign by 
Public Health England (2017) in which e-cigarettes are being promoted as a quit option for smokers, 
highlights the ‘need to carry out research to understand these risks’ while making ‘the best use of the 
situation to reduce tobacco smoking further’ (NHS Health Scotland, 2017). Far from settling the debate, 
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however, some resultant media reports pointed to conflicting draft guidance released simultaneously by 
the UK’s National Institute for Health and Care Excellence (see NICE, 2017) ‘expressing caution about the 
risks and benefits of vaping’ (Donnelly, 2017). 
Polarised views on whether ANDS products will turn out to be ‘good’ or ‘bad’ for public health – or even 
what is meant by ‘good’ and ‘bad’ in light of the TI’s involvement in ANDS – prevail and this is likely to 
remain the case for many years to come while the long-term science is being established. When (or if) it 
does, questions about whether this is ‘science in the private interest’ (Krimsky, 2003) will probably form 
the basis of studies by critical scholars as we have seen with the pharmaceutical, alcohol and processed 
foods industries amongst others (Goldacre, 2012; Moodie, Stuckler, Monteiro et al., 2013).  
The ANDS vacuum has been filled with emotion, beliefs and teleoaffective structures – the ‘tellable 
story’ – with profound implications for both the private sector and civil society actors. Before addressing 
each of these sectors in turn, the challenge of concluding a paper on emotion and belief in ANDS when 
the authors themselves are a part of the same market system is duly noted. This calls for a frank 
disclosure of the difficulties faced in framing and publishing this work, while adopting a neutral 
‘ideological blanksheet’.   
On the one hand, there has been encouragement to robustly question the intentions of tobacco 
companies when ‘thousands of internal tobacco industry documents released through litigation and 
whistleblowers reveal the most astonishing systematic corporate deceit of all time’ (Bates & Rowell, 
2000, p.i). This positioning contests that all morals are not relative and – based on historical attempts to 
influence policy and legal requirements to prioritise profits over health – industry objectivity, science 
and motivations should be called to question. According to this view, adopting a relativistic stance 
serves the interests of industry. 
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On the other hand, industry is contributing to the ANDS evidence base at a speed and volume that far 
outweighs the work of independent researchers. They have the resources to continue to produce the 
science and work with key opinion leaders. They also have the resources to legally challenge obstacles. 
Several leading public health experts and bodies, whether in receipt of industry funding or not, are 
supportive of these products – though many refer to the ANDS market in its entirety as ‘e-cigarettes’ 
when the market is not homogenous but fragmented; comprised of a variety of products ranging in 
safety, efficacy and consumer preference. From this position, criticising e-cigarettes because they are TI 
funded may be putting smokers off quitting smoked tobacco. 
The situation is far from straightforward as alongside industry, all stakeholders – whether journalists, 
journals, researchers, health bodies, funders, policymakers or universities – have some direct and/or 
indirect vested interests, financial or otherwise.  Implications for both the private sector and civil society 
actors follow.  
Private Sector  
Beliefs about tobacco multinationals are tainted by the TI’s deceptive history: they are past masters at 
the tellable story. From the 'Torch of Freedom' to the 'Marlboro Man' they have been able to construct 
narratives that turned an addictive, smelly carcinogen into symbols of female emancipation and rugged 
Americana. Even in the face of an undeniable public health evidence base and direct debunking, these 
myths have been remarkably persistent (Hilts, 1996; Hunt, Hannah & West, 2004). The tellable story of 
THR promises to be even more powerful: it has the potential to make a hero not just of the product but 
the companies themselves; to turn them from pariahs to public health partners. An industry that was 
struggling to recruit a decade ago now has a workforce that is telling itself and other stakeholders 
convincing stories about doing more for public good than some parts of tobacco control. This ability to 
work with uncertainty around ANDS is not surprising for an industry that said “doubt is our product” 
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(Brown & Williamson Records, 1969, p.4) even when there was no doubt. However the story of ANDS, 
we are told, is different from the past: it is about ‘openness and transparency’ not denial and 
manipulation (British American Tobacco, 2016). Furthermore, ANDS has fractured the ‘homogenous 
monolith’ that is the tobacco industry. Different, contradictory tellable stories are emerging from deeply 
competitive tobacco companies.   
The independent ANDS producers can tell equally compelling stories about their fight against tobacco 
and the support they give to and get from their much-maligned customers. They are sometimes 
perceived as the plucky underdogs of the market, with the empowerment and liberation of the hard-
done-by smoker at heart. Innovation is driving their tellable story. 
 
In both cases an important story is not being overtly told, merely assumed: that exploiting nicotine 
dependence for profit is a legitimate business. Whereas a generation ago the TI was deeply embarrassed 
to be, by its own admission, ‘in the business of selling nicotine, an addictive drug’ (Robertson & Hurt, 
2010, p.69), and went as far as committing perjury in the US Congress in its efforts to deny any such 
addictiveness (Robertson & Hurt, 2010), it can now embrace this reality with impunity and even gain 
public health grace in the process.  
The private sector then has an array of tellable stories about ANDS, each giving the impression of being 
tenable in its own right. The disarray in the public health evidence base means that the only constraint 
on these narratives will come from the bottom line.  For the foreseeable future, only the graphs of 
shareholder value will tell us whether ANDS are a silver bullet, a temporary distraction or a public health 
catastrophe in the making – and whether the outcome will be the function of ‘the force of corporate 
marketing’ or ‘a consumer-driven revolution’ will remain a point of contention.   
Civil society 
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Meanwhile the lack of scientific consensus on ANDS has had even more dramatic impacts on civil 
society, where it has torn the tobacco control community apart. On one side, there is ‘traditional public 
health’ which has spent two generations fighting tobacco and the TI, and has much invested in a black 
and white framing: what is good for the TI will necessarily be bad for public health; end of story. It also 
takes a broad view of public health, seeing it as a means of empowering people to take control of their 
own health. This makes addiction, which necessarily undermines agency, a troubling concept for some 
public health researchers who believe that nicotine is, in and of itself, a bad thing and prevention is 
axiomatically better than cure (e.g. Moore, McKee & Daube, 2016; Chapman & Wakefield, 2013; 
Hastings, de Andrade & Moodie, 2012). On the other side is a more focused and medicalised public 
health grouping, which sees the problem specifically in terms of the toxicity of tobacco. Addiction is not 
a problem per se, and nicotine use is only a concern because of the flaws in the delivery device (e.g. 
Britton, Arnott, McNeill, et al., 2016). This group is as comfortable with cure as prevention and has long 
championed intensive cessation services using pharmacotherapies and Nicotine Replacement Therapy 
(NRT).  ANDS are a natural extension of this work and a welcome innovation (e.g. Etter, 2015; Cahn & 
Siegel, 2011).  
Again, therefore, the different actors have tellable stories, each of which is compelling – until you hear 
the other one. The lack of scientific consensus means that both stories prevail: WHO, for example, are 
energetically telling the first, whilst the UK proclaims the latter (e.g. WHO, 2017; Public Health England, 
2017; NHS Health Scotland, 2017). The losers in the resultant muddle are again the general public, who 
get contradictory messages from opposing experts filtered by confused journalists who attempt to 
interpret journal findings and press releases in their efforts to sell stories.  
This raises further questions about the nature of evidence. Nothing is value free: commentaries from 
the media, academia and policymakers create the market and discourses that perpetuate across the 
market constellation. There is nothing outside practice – we are all locked in – so careful self-reflection 
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is needed on our own intentions, motivations and interests. There are serious research implications if 
academics are forced to ‘pick a side’ – pro or anti THR – when presenting ANDS findings. Increasingly, 
papers are rejected for not adopting a firm ideological position often shaped by journal and reviewers’ 
beliefs on the topic. This form of agenda-setting has a profound impact on policy, practice and the 
academy and is personally distressing for researchers, particularly early career academics, who are 
caught in middle of this volatile market.   
Wider implications 
Beyond the specifics of the ANDS market, this victory of story over evidence has profound implications 
for tackling the intractable problems – pollution, climate change, inequalities – that face our species.  
Tobacco control is one of the greatest success stories of public health; literally millions of lives have 
been saved as smoking prevalence has been driven down with a combination of popular empowerment 
and corporate containment. All this depended on a coherent and accepted evidence base; as this has 
fractured so the stories have proliferated and progress has become less certain.  With issues like global 
warming the room for doubt is much greater. We might now be reaching a point where 
anthropomorphic climate change is widely accepted – the election of Donald Trump notwithstanding – 
but we are very far from agreeing on the role economic growth plays in the problem, let alone the 
consumption of specific products or services. This evidence base will be contested with the same energy 
as with ANDS and we can expect many uplifting stories about the green credentials of SUVs and inter-
continental travel. Such are the challenges of regulation in a post-evidence world where wicked 
problems abound and the need for corporate behaviour change becomes more apparent, but also more 
elusive.   
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